XML 21 R25.htm IDEA: XBRL DOCUMENT v2.4.0.6
Derivative Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2013
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule Of Fair Values Of The Company's Derivative Instruments And The Line Items On The Consolidated Balance Sheets
The fair values of the Company’s derivative instruments and the line items on the unaudited condensed consolidated balance sheet to which they were recorded as of March 31, 2013, and December 31, 2012, are summarized as follows (in thousands):
 
Derivative Assets
 
Balance Sheet
Location
 
Fair Value at
March 31, 2013
 
Balance Sheet
Location
 
Fair Value at
December 31, 2012
Derivative assets not designated as hedging instruments
 
Prepaid expenses and other current assets
 
$
967

 
Prepaid expenses and other current assets
 
$
1,142

Derivative assets designated as hedging
instruments
 
Prepaid expenses and other current assets
 
149

 
Prepaid expenses and other current assets
 
2

Total
 
 
 
$
1,116

 
 
 
$
1,144


 
Derivative Liabilities
 
Balance Sheet
Location
 
Fair Value at
March 31, 2013

 
Balance Sheet
Location
 
Fair Value at
December 31, 2012

Derivative liabilities not designated as hedging instruments
 
Other accrued liabilities
 
$
(449
)
 
Other accrued liabilities
 
$
(1,616
)
Derivative liabilities designated as hedging instruments
 
Other accrued liabilities
 
(54
)
 
Other accrued liabilities
 
(3
)
Total
 
 
 
$
(503
)
 
 
 
$
(1,619
)
Offsetting of Derivative Assets
The following tables set forth the offsetting of derivative assets as of March 31, 2013 and December 31, 2012 (in thousands):

As of March 31, 2013
 
 
 
 
 
 
 
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets
 
 
 
Gross Amounts of Recognized Assets
 
Gross Amounts Offset in the Condensed Consolidated Balance Sheets
 
Net Amounts Of Assets Presented in the Condensed Consolidated Balance Sheets
 
Financial Instruments
 
Cash Collateral Pledged
 
Net Amount
Barclays        
 
$
1,009

 
$

 
$
1,009

 
$
(503
)
 
$

 
$
506

Wells Fargo Bank
 
107

 

 
107

 

 

 
107

Total
 
$
1,116

 
$

 
$
1,116

 
$
(503
)
 
$

 
$
613


As of December 31, 2012
 
 
 
 
 
 
 
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets
 
 
 
Gross Amounts of Recognized Assets
 
Gross Amounts Offset in the Condensed Consolidated Balance Sheets
 
Net Amounts Of Assets Presented in the Condensed Consolidated Balance Sheets
 
Financial Instruments
 
Cash Collateral Pledged
 
Net Amount
Barclays        
 
$
1,107

 
$

 
$
1,107

 
$
(1,107
)
 
$

 
$

Wells Fargo Bank
 
37

 

 
37

 
(37
)
 

 

Total
 
$
1,144

 
$

 
$
1,144

 
$
(1,144
)
 
$

 
$

Offsetting of Derivative Liabilities
The following tables set forth the offsetting of derivative liabilities as of March 31, 2013 and December 31, 2012 (in thousands):

As of March 31, 2013
 
 
 
 
 
 
 
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets
 
 
 
Gross Amounts of Recognized Liabilities
 
Gross Amounts Offset in the Condensed Consolidated Balance Sheets
 
Net Amounts Of Liabilities Presented in the Condensed Consolidated Balance Sheets
 
Financial Instruments
 
Cash Collateral Pledged
 
Net Amount
Barclays        
 
$
503

 
$

 
$
503

 
$
(503
)
 
$

 
$

Wells Fargo Bank
 

 

 

 

 

 

Total
 
$
503

 
$

 
$
503

 
$
(503
)
 
$

 
$


As of December 31, 2012
 
 
 
 
 
 
 
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets
 
 
 
Gross Amounts of Recognized Liabilities
 
Gross Amounts Offset in the Condensed Consolidated Balance Sheets
 
Net Amounts Of Liabilities Presented in the Condensed Consolidated Balance Sheets
 
Financial Instruments
 
Cash Collateral Pledged
 
Net Amount
Barclays        
 
$
1,401

 
$

 
$
1,401

 
$
(1,107
)
 
$

 
$
294

Wells Fargo Bank
 
218

 

 
218

 
(37
)
 

 
181

Total
 
$
1,619

 
$

 
$
1,619

 
$
(1,144
)
 
$

 
$
475

Schedule Of Company's Derivative Instruments On Other Comprehensive Income And The Consolidated Statement Of Operations
The effects of the Company’s derivative instruments on OCI and the unaudited condensed consolidated statement of operations for the three months ended March 31, 2013, and April 1, 2012, are summarized as follows (in thousands):

Derivatives Designated as Hedging Instruments
 
Three Months Ended March 31, 2013
 
Gain or (Loss)
Recognized in
OCI -
Effective
Portion (a)
 
Location of
Gain or (Loss)
Reclassified from OCI
into Income - Effective
Portion
 
Gain or (Loss)
Reclassified
from
OCI into
Income -
Effective
Portion (a)
 
Location of
Gain or (Loss)
Recognized in
Income and
Excluded from
Effectiveness  Testing
 
Amount of Gain or (Loss) Recognized in
Income and
Excluded from
Effectiveness  Testing
Cash flow hedges:
 
 
 
 
 
 
 
 
 
 
Foreign currency forward contracts
 
$
178

 
Net revenue
 
$
75

 
Other income (expense), net
 
$
(22
)
Foreign currency forward contracts
 

 
Cost of revenue
 
(2
)
 
Other income (expense), net
 

Foreign currency forward contracts
 

 
Operating expenses
 
(46
)
 
Other income (expense), net
 

Total
 
$
178

 
 
 
$
27

 
 
 
$
(22
)
 
Derivatives Designated as
Hedging Instruments
 
Three Months Ended April 1, 2012
 
Gain or (Loss)
Recognized in
OCI -
Effective
Portion (a)
 
Location of
Gain or (Loss)
Reclassified from OCI
into Income - Effective
Portion
 
Gain or (Loss)
Reclassified
from
OCI into
Income -
Effective
Portion (a)
 
Location of
Gain or (Loss)
Recognized in
Income and
Excluded from
Effectiveness  Testing
 
Amount of Gain  or (Loss)  Recognized in
Income and
Excluded from
Effectiveness  Testing
Cash flow hedges:
 
 
 
 
 
 
 
 
 
 
Foreign currency forward contracts
 
$
(106
)
 
Net revenue
 
$
2

 
Other income (expense), net
 
$
(45
)
Foreign currency forward contracts
 

 
Cost of revenue
 
(2
)
 
Other income (expense), net
 

Foreign currency forward contracts
 

 
Operating expenses
 
(50
)
 
Other income (expense), net
 

Total
 
$
(106
)
 
 
 
$
(50
)
 
 
 
$
(45
)

(a)
Refer to Note 10, Stockholders' Equity, which summarizes the cumulative other comprehensive income activity related to derivatives.
Schedule Of Derivatives Not Designated As Hedging Instruments
The effects of the Company’s derivatives not designated as hedging instruments in other income (expense), net in the unaudited condensed consolidated statements of operations for the three months ended March 31, 2013 and April 1, 2012, are as follows (in thousands):
 
Derivatives Not Designated as Hedging Instruments
 
Location of Gains or (Losses)
Recognized in Income on  Derivative
 
Amount of Gains or (Losses)
Recognized in Income on Derivative
 
Three Months  Ended
March 31, 2013

 
Three Months  Ended
April 1, 2012

Foreign currency forward contracts
 
Other income (expense), net
 
$
268

 
$
(744
)